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Abstract: Inflammatory bowel diseases are characterized by a chronic clinical 
course of relapse and remission associated with self-destructive inflammation 
of the gastrointestinal tract. Active extracts from plants have emerged as natural 
potential candidates for its treatment. Abarema cochliacarpos (Gomes) Barneby & 
Grimes, Fabaceae (Barbatimão), is a native medicinal plant in to Brazil. Previously 
we have demonstrated in an acute colitis model a marked protective effect of a 
butanolic extract, so we decided to assess its anti-inflammatory effect in a chronic 
ulcerative colitis model induced by trinitrobenzensulfonic acid (TNBS). Abarema 
cochliacarpos (150 mg/day, v.o.) was administered for fourteen consecutive days. 
This treatment decreased significantly macroscopic damage as compared with 
TNBS. Histological analysis showed that the extract improved the microscopic 
structure. Myeloperoxidase activity (MPO) was significantly decreased. Study of 
cytokines showed that TNF-α was diminished and IL-10 level was increased after 
Abarema cochliacarpos treatment. In order to elucidate inflammatory mechanisms, 
expression of cyclooxygenase (COX)-2 and nitric oxide synthase (iNOS) were 
studied showing a significant downregulation. In addition, there was reduction in 
the JNK and p-38 activation. Finally, IκB degradation was blocked by Abarema 
cochliacarpos treatment being consistent with an up-regulation of the NF-kappaB-
binding activity. These results reinforce the anti-inflammatory effects described 
previously suggesting that Abarema cochliacarpos could provide a source for the 
search for new anti-inflammatory compounds useful in ulcerative colitis treatment.
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Introduction
 Inflammatory bowel diseases (IBD) such as 
Crohn’s disease (CD) and ulcerative colitis (UC) are 
illness characterized by a chronic clinical course of 
relapse and remission associated with self-destructive 
inflammation of the gastrointestinal tract. IBD has 
long been appreciated to have a genetic basis and 
likely involves a response of the immune system to 
some environmental agent(s). What differentiates the 
inflammatory responses observed in IBD from normal 
gut is an inability to downregulate these responses 
(Gambero et al., 2007; Kaser et al., 2010). One of the 
earliest factors involved is the breach of the intestinal 
epithelial barrier and the development of abnormal 
immune and inflammatory responses that are mediated 
predominantly by activated neutrophils, monocytes, 
lymphocytes, and macrophages (Schmidt & Stallmach, 
2005; Thompson-Chagoyan et al., 2005). Infiltrated 
granulocytes and macrophages produce high levels of 
pro-inflammatory cytokines, such as tumour necrosis 
factor-α (TNF-α), that plays a central role in mucosal 
inflammation and is likely to be at the apex of the 
inflammatory cascade in IBD (Waetzig et al., 2002; 
Talero et al., 2008). Another mediators that have been 
closely associated with the initiation and maintenance 
of intestinal inflammation are COX-2 and iNOS, 
which play a pivotal role in mediating inflammation; 
both produce important inflammatory mediators that 
contribute to loss the integrity of the colonic mucosal 
(Sánchez-Calvo et al., 2009; Sánchez-Fidalgo et al, 
2010).
 Among the signaling pathways which are 
involved in the development or propagation of IBD, 
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the mitogen-activated protein kinases (MAPK) and/
or the nuclear factor ĸB (NF-ĸB) are of particular 
interest (Atreya et al., 2008), by modulating a number 
of different steps in the inflammatory cascade. Recent 
studies have highlighted the importance of the MAPK 
pathway, moreover it has been shown that specific 
inhibitors against p38 and JNK attenuate the disease 
(Kwon et al., 2007; Di Mari et al., 2007; Hollenbach 
et al., 2005; Assi et al., 2006; Broom et al., 2009). 
On the other hand, NF-κB dimers are kept in an 
inactive cytoplasmic complex by inhibitory proteins, 
the inhibitor protein kappa B (IκB) family, in resting 
cells. Phosphorylation of IκB generally leads to the 
rapid dissociation of the complex accompanied by 
proteolytic degradation of IκB and release of NF-κB 
that subsequently transmigrate from cytoplasm into 
the nucleus. NF-κB can induce gene transcription by 
binding to specific promoter elements (Atreya el al, 
2008; Glasgow et al, 2000; Tak & Firestein, 2001).
 Abarema cochliacarpos (Gomes) Barneby & 
Grimes, Fabaceae, is an ornamental tree and native 
medicinal species in to Brazil. It is popularly known 
as “barbatimão” or “babatenã”. It appears mainly in the 
Atlantic Forest and in the Caatinga (dryland) region 
of Northeastern Brazil, which hosts many different 
ethnic communities (Albuquerque et al., 2007; World 
Conservation Center, 1998). In this same region, on the 
traditional medicine of Colônia Treze village (Lagarto/
Sergipe) the decoction of stem bark of Abarema 
cochliacarpos is frequently used for wound-healing, as 
an analgesic and anti-inflammatory (Silva et al., 2006; 
Silva et al., 2009).
 Previous studies performed by our group 
have shown the antiulcer effect of the aqueous extract 
of the bark in experimental alcohol gastric ulcer 
demonstrating for the first time a reduction of the 
lesions (Silva et al., 2006). Recently, the butanolic 
fraction of the methanolic extract was tested on acute 
experimental colitis model induced by trinitrobenzene 
sulfonic acid (TNBS) and showed anti-inflammatory 
effects. Moreover, phytochemical screening of this 
fraction by electrospray ionization (ESI)/MS was also 
performed showing a high content of polyphenols. 
Its major constituents were catechins, flavonoid-type 
compounds and the minor were its dimers and trimers. 
The tannins belong to the proanthocyanidin subgroup. 
The NMR characterization shown the major constituent 
was (+)-catechins (da Silva et al., 2010).
 Ethnopharmacological studies demonstrated 
that Abarema cochliacarpos is used in traditional 
medicine for many diseases, including gastrointestinal 
diseases, through the daily ingestion of this decoction 
or the tincture, which is made by placing the bark in 
white wine or “cachaça” (Silva et al., 2006; Santos, 
2008). Thus, considering this fact, and the promising 
results that have been showed by acute administration 
of butanolic fraction of Abarema cochliacarpos, we 
decided to assess the response and mechanisms involved 
after its chronic administration in experimental colitis 
induced by TNBS.
 We evaluated the inflammatory response 
by histological analysis and by the determination 
of inflammation markers such as MPO activity and 
cytokines profile. In order to gain a better insight into 
the action mechanism(s) the expression of inducible 
enzymes COX-2 and iNOS, the expression and 
activation of MAPKs and IκB degradations were also 
analyzed by Western blotting.
Materials and Methods
Plant material 
 The bark of Abarema cochliacarpos (Gomes) 
Barneby & Grimes, Fabaceae, was obtained from 
collection by Maria Silene da Silva and the folk medicine 
practitioner, in Colônia Treze village, Lagarto city, 
Sergipe state, Brazil, in July 2006. Voucher specimens 
of this species were identified by Prof. Dra. Christine 
Niezgoda from Field Museum of Natural History and 
was deposited under number 007628 at the Federal 
University of Sergipe. 
Preparation of the extract
 Fresh bark of Abarema cochliacarpos was 
dried at room temperature for 10-14 days. Then it was 
powdered (1200 g) and exhaustively extracted with 
methanol (5 L) at room temperature during fifteen days 
at room temperature by maceration. The suspension 
was concentrated at 40 °C under reduced pressure to 
provide a crude metanolic extract with 34.61% yield 
(415.4 g).
 The methanolic extract (200 g) was partitioned 
three times with a mixture of ethyl acetate: water (1:1, 
v/v). The ethyl acetate fraction was evaporated at 35 
°C under reduced pressure to obtain an ethyl acetate 
fraction (AF) of 46.12 g (23.06% yield). The aqueous 
phase was partitioned with a mixture of n-butanol/
water (1:1 v/v, three times), producing 92.62 g of 
butanolic fraction (AC) with 46.31% yield and 45.19 g 
of aqueous fraction (AQF) with 22.59% yield.
Animals
 Male and female Wistar rats supplied by Animal 
Services of the University of Seville, Spain, weighing 180-
200 g, were placed in singled in cages with wire-net floors 
in a controlled room (temperature 24-25 °C, humidity 70-
75%, lighting regimen of 12L/12D) and were fed a normal 
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laboratory diet (Panlab, Barcelona, Spain). Rats were 
deprived of food for 12 h prior to the induction of colitis, 
but were allowed free access to tap water throughout. 
They were randomly assigned to groups of 8-13 
animals. Experiments followed a protocol observed 
by the Animal Ethics Committee of the University of 
Seville and all experiments were in accordance with 
the recommendations of the European Union regarding 
animal experimentation (Directive of the European 
Counsel 86/609/EC).
Induction of colitis 
 Colitis was induced according to the procedure 
described by Morris et al. (1989). Briefly, rats were 
slightly anesthetized with 12% chloral hydrate by 
intraperitoneal route (i.p.) following a 12 h fast, and 
then a medical-grade polyurethane cannula for enteral 
feeding (external diameter 2 mm) was inserted into 
the anus and the tip was advanced to 8 cm proximal 
to the anus verge. TNBS (Sigma-Chemical Co., St. 
Louis, MO, USA) dissolved in ethanol (50%, v/v) was 
instilled into the colon through the cannula (TNBS-30 
mg in a volume of 0.25 mL to induce a long-chronic 
colitis) and the animals were maintained in a head-
down position for a few minutes (2-3 min) to prevent 
leakage of the intracolonic instillate.
 Butanolic fraction of Abarema cochliacarpos 
(150 mg/kg) was suspended in 2% Tween 80 (Sigma-
Chemical Co., St. Louis, MO, USA) (Santos el al, 
2004) and was administered in a volume of 10 mL/kg 
body weight by oral route 24 h after TNBS instillation 
and, daily during the two weeks before the sacrifice. 
We selected this dose of the extract since this was 
the most active in acute study (da Silva et al, 2010). 
A reference control group was applied for comparison 
with the TNBS colon instillation group: the sham group 
that received physiological saline instead of the TNBS 
solution in a comparable volume. Sham and TNBS 
groups also received the vehicle by oral route. The 
rats were checked daily for behavior, body weight, and 
stool consistency.  
Assessment of colitis
 An independent observer who was blinded 
to the treatment evaluated the severity of colitis. For 
each animal, the distal 10 cm portion of the colon 
was removed and cut longitudinally, slightly cleaned 
in physiological saline to remove fecal residues 
and weighed. Macroscopic damage was quantified 
measuring the extent of the lesions in the distal colon 
(mm2) using Bioview 4 (AvSoft, Brazil) an image 
analysis software (Khan, 2004). The presences of 
adhesions (score 0-2), and/or stool consistency (score 
0-1) were evaluated according to the criteria of Bobin-
Dubigeon et al. (2001) with slight modifications. 
Photographs taken from colon samples were digitized 
using Kodak D290 Zoom camera (Eastman Kodak Co., 
Rochester, NY, USA). Pieces of colon were collected 
and frozen in liquid nitrogen for measurement of 
biochemical parameters.
Histological studies
 For examination with the light microscope we 
used tissue samples from the distal inflamed colon of 
each animal and fixed in 4% buffered formaldehyde, 
then submerged into 20-30% sucrose and after 
embebed in tissue freezing medium (Tissue-Tek 
Sakura, Netherlands), and finally were frozen in liquid 
nitrogen. 7 µm thick slices were obtained by utilizing 
a cryostat (HM 525, Microm, Walldorf, Germany) 
and stored at -80 °C until use. The samples were 
stained with hematoxylin–eosin in accordance with 
the standard procedures for histological evaluation of 
colonic damage. All tissue sections were examined in 
an Olympus BH-2 microscope (GMI, MN, USA). Motic 
Images 2000 software was used for characterization of 
histopathological changes.
Assessment of leukocyte involvement
 Myeloperoxidase (MPO) activity, an indicator 
of polymorphonuclear leukocyte accumulation, was 
assessed de according to the method of Bradley et al. 
(1982) with slight modifications. Samples were obtained 
from all animals were weighed and homogenized in 10 
volumes of 50 mM potassium phosphate buffer (PBS), 
pH 7.4. The homogenates were centrifuged at 20,000g, 
20 min, 4 °C. The pellets were again homogenized in 
10 volumes PBS, pH 6.0, containing 0.5% hexadecyl-
trimethylammonium bromide (HETAB) and 10 mM 
ethylenediaminetetraacetic acid (EDTA). These 
homogenates were subjected to one cycle of freezing/
thawing and a brief period of sonication. 
 The supernatants (50 µL) were diluted in 10 
volumes of 50 mM PBS, pH 6. Then it was added 
consecutively 50 µL of O-dianisidine dihydrochloride 
(0.067%), of HETAB (0.5%) and of hydrogen peroxide 
(0.003%). Each well containing the complete reaction 
mixture was incubated for 5 min. The changes in 
absorbance at 450 nm were measured with a microplate 
reader (Labsystem Multiskan EX, Helsinki, Finland). 
One unit MPO activity was defined as the amount of 
enzyme present that produced a change in absorbance 
of 1.0 U/min in the final reaction volume.
Assessment of TNF-α and IL-10 
*
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 Distal colon samples were weighed and 
homogenized, after thawing, in ten volumes PBS, pH 
7.2, 1% bovine serum albumin (BSA) at 4 °C. They were 
centrifuged at 12,00 x g for 10 min and the supernatants 
were collected and stored at -80 °C. Mucosal 
cytokines levels were assayed with quantitative TNF-α 
(eBioscience, San Diego,CA ) and IL-10 (Diaclone, 
Besançon,France) enzyme immunoassay kits. TNF-α 
and IL-10 values were expressed as pg/mg tissue.
Western blotting assay
 Frozen colonic tissues were weighed and 
homogenized in ice cold buffer (50 mM Tris-HCl, 
pH 7.5, 8mM MgCl2, 5mM ethylene glycol bis 
(2-aminoethyl ether)-N,N,N’N’-tetraacetic acid 
(EGTA), 0.5 mM EDTA, 0.01 mg/mL leupeptin, 
0.01 mg/mL pepstatin, 0.01 mg/mL aprotinin, 1 mM 
phenylmethylsulfonyl fluoride (PMSF) and 250 mM 
NaCl. Homogenates were centrifuged (12000 x g, 15min, 
4 °C) and the supernatants were collected and stored at 
-80 °C. Protein concentration of the homogenate was 
determined following Bradford’s colorimetric method. 
Aliquots of supernatants containing equal amounts of 
protein (50 µg) were separated on 10% acrylamide 
gel by sodium dodecyl sulfate polyacryamide gel 
electrophoresis. In the next step, the proteins were 
electrophoretically transferred onto a nitrocellulose 
membrane and incubated with specific primary 
antibodies: rabbit polyclonal anti-COX-2 and anti-
iNOS (Cayman Chemical, USA) at dilution of 1:3000, 
mouse polyclonal anti- JNK and anti-pJNK (Cell 
Signalling Technology, USA) at dilution of 1:2000 and 
1:500 respectively, and mouse polyclonal anti-p38 and 
anti-p-p38 (Santa Cruz Biotecnology, Inc) at dilution 
of 1:1000 overnight at 4 ºC. After, each filter was 
washed three times for 15 min and incubated with the 
anti-rabbit (Pierce Biotechnology, IL, U.S.A) and anti-
mouse (Sigma-Aldrich, MO, USA) immunoglobulin 
G antibodies respectively. To prove equal loading, 
the blots were analyzed for β-actin expression using 
an anti-β-actin antibody (Sigma-Aldrich, MO, USA). 
Immunodetection was performed using enhanced 
chemiluminiscence light-detecting kit (SuperSignal® 
West Femto Chemiluminescent Substrate, Pierce, IL, 
USA). Densitometric data were studied following 
normalization to the control (housekeeping gene). The 
signals were analyzed and quantified by a Scientific 
Imaging Systems (KODAK 1D, Image Analysis 
Software).
IκBα degradations analysis
 Using the western blot technique as herein 
before narrated for cytoplasmic protein extracts, it 
was evaluated degradations of cytoplasmic IκB protein 
of intestinal mucosa. The specific primary antibody 
used was rabbit polyclonal anti-IκBα (Cell Signalling 
Technology, USA) at dilution of 1:1000 and the next 
day with the anti-rabbit immunoglobulin G antibodies 
(Pierce Biotechnology, IL, USA).
Statistic analysis
 All values in the figures and text are expressed 
as arithmetic means±standard error of the mean (SEM). 
Data were evaluated with Graph Pad Prism1 Version 5 
software. The statistical significance of any difference 
in each parameter among the groups was evaluated 
by one-way analysis of variance (ANOVA) followed 
by Tukey test. p values of <0.05 were considered 
statistically significant. In the experiment involving 
histology, the figures shown are representative of at 
least three experiments performed on different days. 
Results 
 At fourteen days after intracolonic 
administration of TNBS, control animals underwent 
severe anorexia with a marked body weight loss 
and intense diarrhea in the majority of animals in 
comparison with sham group (p<0.001). Presence of 
adhesions to adjacent organs and a marked increase in 
the weight/length of the colon were also observed in 
TNBS treated rats (p<0.001) (Table 1). Macroscopic 
inspection of the colon after two weeks of colitis 
induction showed a flaccid appearance, bowel wall 
thickening, inflammation and ulcers. The damage was 
Table 1. Quantified parameters after administration of butanolic fraction of bark of Abarema cochliacarpos (AC, 150 mg/kg) 
in rats with chronic colitis induced by trinitrobenzene sulfonic acid (TNBS) intracolonic instillation (30 mg/animal).
Group n Body weight Adhesions (score 0-2) Diarrhea (score 0-1) Colon weight∕length 
(g∕cm)
Mortality (%)
Sham 8 180.25±3.14 0 0 0.09±0.004 0
TNBS-30 8 163.40±3.19 1.80±0.20 0.83±0.16 0.56±0.09 40
AC 150 8 172.23±2.93 1.20±0.20 0.25±0.25 0.29±0.03 20
Colonic parameters were quantified in the sham group, which received saline instillation. TNBS group received the hapten intracolonically in a vehicle 
of 50% (v/v) ethanol. Data are expressed as mean±SEM. (***) p<0.001 vs. sham group; (+) p<0.05 and (++) p<0.01 vs. TNBS control group
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TNBS was also characterized by a marked increase in 
MPO activity (2.43±0.80 U/mg tissue, p<0.01 vs sham 
group), an indicator of the infiltration of the colon 
with polymorphonuclear leukocytes. This result was 
consistent with the histological findings. This assay 
of MPO activity showed that Abarema cochliacarpos 
significantly reduced the degree of polymorphonuclear 
neutrophil infiltration as compared to TNBS group 
(0.54±0.16 U/mg tissue, p<0.05 vs. TNBS group).
 Regarding the pro-inflammatory cytokines 
production, the colonic injury provoked by 30 mg of 
TNBS administration by animal was characterized by 
a significant increase in TNF-α levels (40.95±5.45 pg/
mg tissue, p<0.01 vs. sham group). After treatment 
with Abarema cochliacarpos, data clearly indicated a 
significant reduction in this cytokine (18.94±0.44 pg/
mg tissue, p<0.01, vs. TNBS group) (Figure 1C).
 In contrast, IL-10 levels were diminished 
in TNBS control group (2.05±0.71 pg/mg tissue, 
p<0.05 vs. sham group) and Abarema cochliacarpos 
administration increased IL-10 levels, reaching values 
similar to sham group (6.63±0.70 pg/ mg tissue, p<0.01 
vs. TNBS group) (Figure 1D). 
 The levels of expression of COX-2 and iNOS 
were measured by western blotting of cytosolic extracts 
from colonic mucosa. Exposure of colon to TNBS 
caused strong expression of COX-2 and iNOS (p<0.001 
and p<0.01 respectively), indicating that these proteins 
expression could be induced at the chronic stage of 
colonic lesion caused by TNBS. Nevertheless, oral 
administration of Abarema cochliacarpos was able to 
diminish significantly the up-regulation of both COX-2 
quantified and the affected area was 1169±116.30 mm2 
(p<0.001) (Figure 1A and Figure 2B).
 After Abarema cochliacarpos treatment in 
TNBS-rats during 14 days, significant changes were 
observed respect to the presence of diarrhea (p<0.05), 
adhesions to adjacent organs (p<0.05) and colon weight/
length (p<0.01) vs. TNBS control group; although 
no significant reduction in the body weight loss was 
observed. Treatment with Abarema cochliacarpos 
also significantly ameliorated the extent and severity 
of the colonic inflammation, reflecting signs of 
greater recovery as evidenced by the quantification of 
macroscopic damage (291.8±10.82 mm2; p<0.001 vs. 
TNBS group) as is reflect in Figure 1A and Figure 2C.
 The histological analysis of the colon of 
sham-treated rats showed typical features of normal 
structure (Figure 2D). In TNBS-treated rats, the 
inflammation extended through the mucosa and 
submucosa. Extensive granulation tissue with presence 
of fibroblasts and lymphocytes, leukocytes, and diffuse 
inflammatory infiltrates was apparent (Figure 2E). The 
mucosa adjacent to lesions showed extensive crypt 
distortion and goblet cells were totally absent at the 
surface epithelium. After chronic administration of 
Abarema cochliacarpos, the colonic histopathology 
was dramatically reduced: there was an attenuation of 
morphological signs of cell damage; the colonic mucosa 
showed ulcers in the process of healing, goblet cells 
were most visible and a repair process was observed in 
some areas. The mucosa showed a healing course with 
signs of mucosal reepithelization (Figure 2F, 2G).
 As shown in Figure 1B, the colitis caused by 
Figure 1. Effect of chronic administration of butanolic fraction of Abarema cochliacarpos (AC) on colonic macroscopic damage 
(A), myeloperoxidase activity (MPO, U/mg tissue) (B) , tumor necrosis factor-alpha (TNF-α, pg/mg tissue) (C), and interleukin-10 
(IL-10, pg/mg tissue) (D), in trinitrobenzene sulfonic acid-induced colitis model in rats (TNBS, 30 mg/animal).The control-sham 
group received physiological saline instead of the TNBS solution in an equal volume. Data are expressed as the means ± S.E.M. 
One way ANOVA followed by Tukey’s test. *p<0.05; **p<0.01; ***p<0.001 vs sham; +p<0.05; ++p<0.01 and +++p<0.001 vs 
TNBS group.
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and iNOS proteins (p<0.05, vs TNBS) (Figure 3A, 
3B).
 JNK and p38 MAPK protein activation was also 
detected in cytosolic extracts of normal colon mucosa by 
western blot using phosphospecific MAPK antibodies 
(Figure 4). To standardize protein loading in each line, 
blots were stripped and re-probed with the corresponding 
antibodies against both proteins. Phosphorylation of JNK 
protein was not detected in cytosolic extracts of normal 
colon mucosa, whereas a high expression appeared in 
colon mucosa from control TNBS-treated rats (p<0.01 vs. 
sham group), indicating that JNK protein activation could 
be induced at the chronic stage of colonic lesion caused 
by TNBS. Nonetheless, upon treatment with Abarema 
cochliacarpos the protein expression of p-JNK was 
significantly decreased (p<0.05 vs TNBS group) (Figure 
4A). Study from p38 protein showed that it remained 
unchanged in all groups, indicating that this protein was 
constitutively expressed in the colonic tissue and, its 
activation was significantly changed after TNBS-enema 
(p<0.001 vs. sham group). Chronic Abarema cochliacarpos 
Figure 2. Effect of butanolic fraction of Abarema cochliacarpos on colon injury in chronic colitis model induced by 
trinitrobenzene sulfonic acid (TNBS, 30 mg/animal). Representative macroscopic and histological appearance of rat colonic 
mucosa in control animals (A and D respectively), TNBS treatment (B and E respectively) and butanolic fraction of Abarema 
cochliacarpos-treated animals (150 mg kg-1 v.o.) (C, F and G respectively). TNBS lesions were characterized by necrosis of 
epithelium, focal ulceration and diffuse infiltration of inflammatory cells in the mucosa and submucosa. Hematoxylin and 
eosin. Original magnification: D, E and F 100X; G, 200X.
administration demonstrated a significantly reduction of 
phosphorylation of this protein (p<0.05 vs TNBS group) 
(Figure 4B).
 Since NF-κB activity is controlled by the steady 
state level of IκBα we further investigated the effect 
of Abarema cochliacarpos on IκB degradation in rat’s 
colonic mucosa. As shown in Figure 5, protein extracts 
of colon tissues showed that intestinal inflammation 
of TNBS group induced a significant IκB degradation 
which is consistent with an up-regulation of the NF-
kappaB-binding activity. However, this was blocked by 
Abarema cochliacarpos treatment.
Discussion
 In particular we have demonstrated that fourteen 
days of Abarema cochliacarpos treatment decreased the 
degree of adhesions, diarrhea and colon weight/length, 
as well as colonic macroscopic damage. There was 
an attenuation of morphological signs of cell damage, 
the colonic mucosa showed ulcers at the beginning of 
Chronic administration of Abarema cochliacarpos attenuates colonic 
inflammation in rats
Maria Silene da Silva et al.
Rev. Bras. Farmacogn. Braz. J. Pharmacogn. 21(4): Jul./Aug. 2011686
reepithelization and healing process. The infiltration of 
polymorphonuclears and the increase on TNF-α production 
caused by TNBS in the colon were also diminished 
after Abarema cochliacarpos treatment. Moreover, 
administration of the extract was able to increase the 
levels of the anti-inflammatory cytokine IL-10, which 
were diminished after TNBS administration. COX-2 and 
iNOS proteins were downregulated after administration 
of Abarema cochliacarpos as well as the intestinal 
phosphorylation of JNK and p38. Moreover, this extract 
blocked IκB degradation.
 As we have mentioned above phytochemical 
screening results from butanolic fraction of Abarema 
cochliacarpos demonstrated that its main bioactive 
constituents is (+)-catechin (da Silva et al, 2010). Several 
studies have demonstrated that catechins intake has 
been associated with a wide whose variety of beneficial 
health effects in vitro, in vivo and clinically, including 
experimental model of ulcerative colitis (Sato et al, 1998; 
Mazzon et al, 2005), although its mechanism of action is 
unknown yet.
 Studies of bioavailability of catechins show that 
although most of an oral dose of catechins remains in the 
gut and becomes available for metabolism by the colonic 
microflora, some certainly are absorbed and appear in the 
plasma (Gee & Johnson, 2001; Nakagawa & Miyazawa, 
1997). Conversely, Okushio et al. (1996) confirmed that 
the principal catechins of green tea are absorbed in the 
rat small intestine by measuring their appearance in the 
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Figure 3. Effects of chronic administration of butanolic fraction 
of Abarema cochliacarpos (AC150 mg/kg) on cycloxygenase-2 
(COX-2) and inducible nitric oxide synthase (iNOS) (A and B) in 
trinitrobenzene sulfonic acid (TNBS, 30 mg/animal). The results 
are representative of three experiments performed on different 
samples. Data are expressed as the means±SEM. One way 
ANOVA followed by Tukey’s test. **p<0.01 and ***p<0.001 vs 
sham; +p<0.05 vs TNBS.
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Figure 4. Effects of chronic administration of butanolic fraction of Abarema cochliacarpos (AC150 mg/kg) on activation of 
the JUNK and p38 MAPKs proteins in trinitrobenzene sulfonic acid (TNBS, 30 mg/animal).The results are representative of 
three experiments performed on different samples. Data are expressed as the means±S.E.M. One way ANOVA followed by 
Tukey’s test. **p<0.01 and ***p<0.001 vs sham, +p<0.05 and ++p<0.01 vs TNBS.
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portal circulation after an oral dose. All these observations 
may have significance on the beneficial effect of Abarema 
cochliacarpos in our ulcerative chronic colitis model.
 Whatever the trigger of IBD, neutrophils are early 
responders and play a central role in the inflammatory 
process. During the initial innate immune response, they 
are seen passing from the circulation through gaps in the 
vascular endothelium to infiltrate the tissues (Villegas et 
al., 2003). Once there, neutrophils release antimicrobial 
peptides, as enzyme MPO, which catalyses the formation of 
such potent cytotoxic oxidants as hypochlorous acid from 
hydrogen peroxide and chloride ions and N-chloramines 
(Martin et al., 2006) and reactive oxygen intermediates 
that may in themselves cause further tissue damage 
(Hanauer, 2006).The increase in MPO activity in TNBS-
treated animals was reduced after chronic administration 
of Abarema cochliacarpos. Microscopic evaluation also 
revealed an increased number of neutrophil leukocytes 
that possibly contributed to the elevated MPO activity 
observed in TNBS group. This anti-inflammatory effect has 
already been demonstrated after acute treatment (da Silva 
et al., 2010), but we confirm these previous results and 
demonstrate that this effect has been higher after chronic 
treatment. The antioxidant activity of phenol compounds, 
as well as catechins, has been shown by many studies. In 
this way, the reduction in colonic MPO activity as well 
as the reduction of cellular infiltration after treatment with 
Abarema cochliacarpos may be reflective of its antioxidant 
and anti-inflammatory effects.
 Some works by our group have shown that in this 
well-characterized TNBS-induced colitis model mucosal 
pro-inflammatory cytokines increase, such as IL-1β, IL-6 
and TNF-α, induces the production of chemoattractants for 
neutrophils, which regulate endothelial adhesion molecules 
expression on vascular endothelial cells and promote 
neutrophil adherence to these cells (Sánchez-Fidalgo et 
al., 2007; Camacho-Barquero et al., 2007; Talero et al., 
2008; Sánchez-Calvo et al., 2009). On the other hand, 
the cytokine IL-10 inhibits both antigen presentation and 
subsequent release of pro-inflammatory cytokines, thereby 
attenuating mucosal inflammation in IBD (Sanchez-Muñoz 
et al., 2008). This anti-inflammatory cytokine possesses 
important immune-modulatory properties and its deficiency 
allows for the development of unrestrained activation of 
a Th-1-mediated immune response (Wirtz & Neurath, 
2007), as it occurs in the spontaneous colitis induced in IL-
10–knockout mice (Strober et al., 2002). Therefore, it has 
been suggested that using different strategies that increase 
IL-10 may be useful in IBD therapy.
 The present results show that chronic 
administration of Abarema cochliacarpos was able to 
diminish TNF-α levels and significantly to increase IL-
10 levels. These results are of interest since although the 
diminution of TNF-α levels after Abarema cochliacarpos 
administration has been observed in the acute colitis 
model (da Silva et al., 2010), the increase of the anti-
inflammatory IL-10 cytokine after chronic treatment has 
not been demonstrated yet. Thus, chronic administration of 
(+) catechins from Abarema cochliacarpos seems capable 
to modulate the Th1/Th2 response, which may be other of 
the mechanisms of action responsible to the improvement 
of the colitis. Previous studies have shown as epicatechins 
from green tea extracts exhibit similar effects, they 
decreased TNF-α in others IBD models (Mazzon et al., 
2005; Ran et al., 2008; Varilek et al., 2001) and stimulated 
IL-10 production in human leukocytes (Crouvesier et al., 
2001).
 Macroscopic damage in this chronic colitis model 
was associated with both COX-2 and iNOS overexpression 
and, (+)-catechins from Abarema cochliacarpos fraction 
significantly down regulated both proteins. Many 
researchers show the effects of catechins on COX-2 and 
iNOS activities in different in vivo and in vitro studies 
(Seeram et al., 2003; Peng et al., 2006; Chan et al., 1997; 
Shirakami, et al., 2008; Ran et al., 2008), demonstrating its 
involvement on COX-2 and iNOS expression. Therefore, 
these findings are significant since it has been shown as 
inhibition of both proteins by Abarema cochliacarpos 
administration improves chronic inflammation in this 
disease.
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Figure 5. Effects of chronic administration of butanolic fraction 
of Abarema cochliacarpos (AC150 mg/kg) on degradation of 
the IĸBα protein in trinitrobenzene sulfonic acid (TNBS, 30 
mg/animal).The results are representative of three experiments 
performed on different samples. Data are expressed as the 
means±S.E.M. One way ANOVA followed by Tukey’s test. 
***p<0.001 vs sham and ++p<0.01 vs TNBS.
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 In order to deep in the mechanism of action, 
MAPKs and NFκB activation were studied. MAPKs have 
been implicated in many physiologic processes, including 
cell proliferation, differentiation, and death. The three 
major types of MAPKs in mammalian cells are ERK, the 
p38 MAPKs, and JNK, which support a role in mediating 
IBD (Broom et al., 2009). In this study, we showed that 
activation of JNK and p38 by TNBS was downregulated 
by (+)-catechins from Abarema cochliacarpos, which is 
of interesting because inflammatory responses - mainly 
cytokine production, inflammatory cell infiltration and 
COX-2 and iNOS upregulation- have been shown to be 
attenuated by usage of specific inhibitors against JNK and 
p38 MAPKs (Kwon et al., 2007; Hayashi, 2000; Di Mari 
et al., 2007; Hollenbach et al., 2005; Assi et al., 2006; 
Broom et al., 2009). On the other hand, NFκB could be 
an important molecular target and its activation has been 
linked to inflammation. Phosphorylation of IκB generally 
leads to the degradation of IκBα, with the concomitant 
release of NFκB and nuclear translocation of NFκB, which 
binds to the promoter of many pro-inflammatory genes, 
most notably iNOS, COX-2, and TNF among others 
(Cheung & Kong 2010). We have demonstrated that the 
extract of Abarema cochliacarpos was able to block the 
degradation of IκBα. 
 Recently, catechins have been shown to inhibit 
the MAPK pathway and NF-κB activity (Kim et al., 2009; 
Guiterrez-Orozco et al., 2010). Consistent with these 
reports, our findings suggest that the inhibition of MAPK 
activation and NF-κB activity might be a good therapeutic 
strategy for TNBS-induced ulcerative colitis and propose 
that the inhibitory effect of catechins from Abarema 
cochliacarpos on inflammatory mediator expression 
could be mediated, at least in part, by blocking the MAPK 
pathway with subsequent inhibition of NF-κB activity.
 In conclusion, this study demonstrates that 
the degree of colitis caused by administration of TNBS 
is significantly attenuated by (+) catechin, the major 
constituent of Abarema cochliacarpos. The anti-
inflammatory effects are associated with (i) a reduction 
in pro-inflammatory T-helper 1 cytokine response, (ii) 
an increase in anti-inflammatory T-helper 2 cytokine 
response leading to the attenuation of the recruitment of 
neutrophils, (iii) attenuation of COX-2 and iNOS proteins 
expression potentially by modulation of MAPK pathway 
and inhibition of NF-κB activity. In conclusion, these 
results reinforce the anti-inflammatory effects described 
previously, suggesting that Abarema cochliacarpos could 
provide a source for the search for new anti-inflammatory 
compounds useful in ulcerative colitis treatment
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